J&J Considers Sale, Spin-Off For Ortho-Clinical Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson announced plans to evaluate strategic options for its Ortho-Clinical Diagnostics unit during the firm’s medical devices and diagnostics business review.